Jagsonpal Pharmaceuticals Ltd.
|
Ratio Analysis
|
|
You can view the
Ratio Analysis
for the last 5 years.
Market Cap. (Rs.)
|
841.25 Cr.
|
P/BV
|
5.29
|
Book Value (Rs.)
|
60.14
|
52 Week High/Low (Rs.)
|
515/274
|
FV/ML
|
5/1
|
P/E(X)
|
31.48
|
Bookclosure
|
21/08/2023
|
EPS (Rs.)
|
10.11
|
Div Yield (%)
|
1.57
|
|
Months | 12 | 12 | 12 | 12 | 12 |
Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
FaceValue | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 |
| | | | | |
PER SHARE RATIOS | | | | | |
| | | | | |
Basic EPS (Rs.) | 10.20 | 7.48 | 6.51 | 3.00 | 2.75 |
Diluted EPS (Rs.) | 10.20 | 7.48 | 6.51 | 3.00 | 2.75 |
Cash EPS (Rs.) | 10.66 | 8.06 | 6.71 | 3.44 | 3.14 |
Book Value[Excl.RevalReserv]/Share (Rs.) | 60.65 | 46.96 | 43.55 | 39.39 | 36.89 |
Book Value[Incl.RevalReserv]/Share (Rs.) | 60.65 | 49.95 | 46.54 | 42.38 | 39.88 |
Dividend / Share (Rs.) | 5.00 | 4.00 | 1.00 | 0.50 | 0.25 |
Revenue From Operations / Share (Rs.) | 90.36 | 86.30 | 71.74 | 60.53 | 64.22 |
PBDIT / Share (Rs.) | 15.22 | 11.12 | 8.96 | 4.22 | 4.11 |
PBIT / Share (Rs.) | 14.76 | 10.54 | 8.76 | 3.79 | 3.72 |
PBT / Share (Rs.) | 13.29 | 10.43 | 8.35 | 3.59 | 3.44 |
Net Profit / Share (Rs.) | 10.20 | 7.48 | 6.51 | 3.00 | 2.75 |
| | | | | |
PROFITABILITY RATIOS | | | | | |
| | | | | |
PBDIT Margin (%) | 16.84 | 12.88 | 12.48 | 6.97 | 6.39 |
PBIT Margin (%) | 16.34 | 12.20 | 12.21 | 6.26 | 5.79 |
PBT Margin (%) | 14.70 | 12.08 | 11.63 | 5.93 | 5.35 |
Net Profit Margin (%) | 11.28 | 8.66 | 9.07 | 4.96 | 4.28 |
Return on Networth / Equity (%) | 16.81 | 15.92 | 14.95 | 7.62 | 7.46 |
Return on Capital Employeed (%) | 23.10 | 20.55 | 18.54 | 8.69 | 9.06 |
Return On Assets (%) | 13.70 | 11.62 | 10.38 | 5.35 | 5.31 |
Total Debt / Equity (X) | 0.00 | 0.00 | 0.05 | 0.04 | 0.03 |
Asset Turnover Ratio (%) | 1.30 | 1.36 | 1.21 | 1.12 | 1.27 |
| | | | | |
LIQUIDITY RATIOS | | | | | |
| | | | | |
Current Ratio (X) | 5.97 | 3.24 | 2.98 | 2.89 | 3.46 |
Quick Ratio (X) | 5.22 | 2.37 | 2.25 | 2.00 | 2.30 |
Inventory Turnover Ratio (X) | 1.24 | 1.36 | 1.31 | 1.19 | 0.92 |
Dividend Payout Ratio (NP) (%) | 0.00 | 53.50 | 15.35 | 16.64 | 10.94 |
Dividend Payout Ratio (CP) (%) | 0.00 | 49.63 | 14.91 | 14.55 | 9.59 |
Earning Retention Ratio (%) | 0.00 | 46.50 | 84.65 | 83.36 | 89.06 |
Cash Earning Retention Ratio (%) | 0.00 | 50.37 | 85.09 | 85.45 | 90.41 |
| | | | | |
COVERAGE RATIOS | | | | | |
| | | | | |
Interest Coverage Ratio (%) | 96.57 | 102.18 | 21.61 | 21.51 | 14.44 |
Interest Coverage Ratio (Post Tax) (%) | 74.08 | 69.70 | 16.71 | 16.31 | 10.68 |
| | | | | |
VALUATION RATIOS | | | | | |
| | | | | |
Enterprise Value (Cr.) | 644.85 | 795.42 | 154.96 | 12.31 | 34.15 |
EV / Net Operating Revenue (X) | 2.72 | 3.52 | 0.82 | 0.07 | 0.20 |
EV / EBITDA (X) | 16.17 | 27.31 | 6.60 | 1.11 | 3.17 |
MarketCap / Net Operating Revenue (X) | 3.21 | 3.63 | 1.11 | 0.28 | 0.40 |
Retention Ratios (%) | 0.00 | 46.49 | 84.64 | 83.35 | 89.05 |
Price / BV (X) | 4.78 | 6.68 | 1.83 | 0.44 | 0.71 |
Price / Net Operating Revenue (X) | 3.21 | 3.63 | 1.11 | 0.28 | 0.40 |
EarningsYield | 0.03 | 0.02 | 0.08 | 0.17 | 0.10 |